Indicator summary: Bullish (4 bullish, 0 bearish, 1 neutral). As of 2026-10-08, the close was $272.42: 5.4% above the 50-day average and 18.2% above the 200-day average, which is rising. RSI (14) is 67, in its neutral range. MACD is bullish after a cross in the last 10 days. The stock sits 97% of the way up its 52-week range of $189.41 to $274.94, on 1.0x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $258.51 | Price 5.4% above |
| 200-day average | $230.48 | Price 18.2% above, average rising |
| 50 vs 200-day | 50 above 200 | Golden-cross alignment |
| RSI (14) | 67 | Neutral range |
| MACD (12, 26, 9) | +2.84 vs +2.26 | Bullish cross in the last 10 days |
| 52-week range | $189.41 to $274.94 | 97% of the way up the range |
| Volume vs 20-day average | 1.0x | Normal |
Base rates use ABBV's own daily history since 2013; they describe the past, not a forecast.
As of 2026-10-08, ABBV's 14-day RSI is 67, which is in the neutral range between 30 and 70.
Yes. ABBV closed at $272.42 on 2026-10-08, 18.2% above its 200-day average of $230.48, which is rising. When it closed above its 200-day average (2,318 days), it was higher 63 trading days later 60% of the time, median +3.0%.
Yes. ABBV closed at $272.42 on 2026-10-08, 5.4% above its 50-day average of $258.51. When it closed above its 50-day average (2,093 days), it was higher 63 trading days later 58% of the time, median +2.5%.
Yes, a bullish cross within the last 10 trading days. As of 2026-10-08 the MACD line is +2.84 against a signal line of +2.26, so MACD is bullish.
Yes. At $272.42 it sits 97% of the way up its 52-week range of $189.41 to $274.94, 0.9% below the high.
Bullish: 4 of 5 indicators are bullish and 0 bearish as of 2026-10-08 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: Sell, from the chart signal model.
ABBV analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.